Yatharth Hospital & Trauma Care Services Ltd is Rated Hold

1 hour ago
share
Share Via
Yatharth Hospital & Trauma Care Services Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 10 Apr 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 16 May 2026, providing investors with an up-to-date analysis of the company’s performance and outlook.
Yatharth Hospital & Trauma Care Services Ltd is Rated Hold

Rating Overview and Context

On 10 Apr 2026, MarketsMOJO revised the rating of Yatharth Hospital & Trauma Care Services Ltd from 'Sell' to 'Hold', reflecting a significant improvement in the company’s overall profile. The Mojo Score increased by 17 points, moving from 48 to 65, signalling a more balanced risk-reward profile for investors. This 'Hold' rating suggests that while the stock is not currently a strong buy, it offers reasonable stability and potential for moderate returns, making it suitable for investors seeking cautious exposure to the hospital sector.

Here’s How the Stock Looks Today

As of 16 May 2026, Yatharth Hospital & Trauma Care Services Ltd exhibits a mixed but generally positive set of fundamentals. The company operates in the hospital sector and is classified as a smallcap stock. Despite a modest market capitalisation, the firm has demonstrated resilience and growth, which is reflected in its current financial and technical metrics.

Quality Assessment

The company holds an average quality grade, indicating a stable operational foundation but with room for improvement in certain areas. Notably, Yatharth Hospital is net-debt free, a significant strength that reduces financial risk and enhances balance sheet flexibility. The firm has reported positive results for ten consecutive quarters, underscoring consistent operational performance. Quarterly net sales have reached a high of ₹320.47 crores, with PBDIT peaking at ₹74.25 crores and PAT at ₹45.35 crores, signalling robust profitability trends.

Valuation Considerations

Valuation remains a key factor in the current rating. The stock is considered expensive, trading at a price-to-book value of 4.7, which is a premium relative to its peers’ historical averages. This elevated valuation reflects investor confidence but also implies limited margin for valuation expansion. The company’s return on equity (ROE) stands at 9%, which, while respectable, does not fully justify the premium valuation. The PEG ratio of 1.6 suggests that the stock’s price growth is somewhat ahead of its earnings growth, warranting a cautious stance from value-conscious investors.

Financial Trend and Profitability

Financially, Yatharth Hospital & Trauma Care Services Ltd shows a positive trend. Over the past year, the stock has delivered an impressive 65.40% return, significantly outperforming the broader market benchmark BSE500, which has declined by 1.67% in the same period. Profit growth has been strong, with a 28.6% increase in profits over the last year, reflecting effective management and operational efficiency. The company’s consistent quarterly performance and net-debt-free status contribute to a solid financial foundation.

Technical Outlook

From a technical perspective, the stock is rated bullish. Despite a recent one-day decline of 2.04% and a one-week drop of 5.46%, the medium-term momentum remains positive. The stock has gained 3.52% over the past month and 18.89% over three months, indicating sustained buying interest. Year-to-date, the stock is up 19.65%, reinforcing the bullish technical sentiment. This technical strength supports the 'Hold' rating, suggesting that while the stock may experience short-term volatility, the overall trend remains upward.

Implications for Investors

The 'Hold' rating on Yatharth Hospital & Trauma Care Services Ltd advises investors to maintain their current positions without initiating new purchases or sales aggressively. The company’s strong financial health, consistent profitability, and positive technical indicators provide a foundation for steady performance. However, the expensive valuation and average quality grade suggest that investors should monitor the stock closely for any changes in fundamentals or market conditions that could affect its outlook.

Market-Beating Performance Despite Sector Challenges

It is noteworthy that Yatharth Hospital has outperformed the broader market significantly over the past year, delivering returns of 65.40% compared to the BSE500’s negative 1.67%. This outperformance highlights the company’s ability to generate shareholder value even in challenging market environments. The majority shareholding by promoters also indicates stable ownership, which can be a positive factor for long-term investors.

Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!

  • - New profitability achieved
  • - Growth momentum building
  • - Under-the-radar entry

Get In Before Others →

Summary

In summary, Yatharth Hospital & Trauma Care Services Ltd’s current 'Hold' rating reflects a balanced view of its strengths and challenges. The company’s net-debt-free status, consistent profitability, and bullish technical outlook are offset by an expensive valuation and average quality grade. Investors should consider these factors carefully when evaluating the stock for their portfolios. The rating indicates that the stock is fairly valued at present, with potential for moderate gains but also some risk due to valuation levels.

Looking Ahead

Going forward, investors should watch for continued earnings growth and any shifts in valuation multiples. Maintaining a close eye on quarterly results and sector developments will be crucial to reassessing the stock’s attractiveness. The hospital sector’s dynamics, including regulatory changes and healthcare demand trends, will also influence Yatharth Hospital’s prospects.

Conclusion

Yatharth Hospital & Trauma Care Services Ltd’s 'Hold' rating by MarketsMOJO as of 10 Apr 2026, supported by current data as of 16 May 2026, suggests a cautious but optimistic stance. The stock offers a blend of growth potential and stability, suitable for investors seeking exposure to the hospital sector without excessive risk. Monitoring valuation and financial trends will be key to making informed investment decisions in the coming months.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News